MR Imaging of Urinary Bladder Carcinoma and Beyond

Radiologic Clinics of North America

Volumn 50, Issue 6, 2012, Pages 1085-1110

  Raza, Syed Arsalan ^a,b   Jhaveri, Kartik S ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Bladder cancer; Bladder carcinoma; Magnetic resonance imaging; Nonneoplastic bladder abnormalities; Urinary bladder; Urothelial carcinoma of urinary bladder

Indexed keywords

BLADDER CARCINOMA; BLADDER DIVERTICULUM; CANCER GENETICS; CANCER STAGING; CLINICAL ASSESSMENT; COILED BODY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; ENDOMETRIOSIS; HUMAN; LEIOMYOMA; LEIOMYOSARCOMA; LYMPHOMA; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLIATIVE THERAPY; PARAGANGLIOMA; PRIORITY JOURNAL; PSEUDOSARCOMA; REVIEW; RHABDOMYOSARCOMA; SALVAGE THERAPY; SQUAMOUS CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION;

ARTIFACTS; CARCINOMA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84868289117     PISSN: 00338389     EISSN: 15578275     Source Type: Journal    
DOI: 10.1016/j.rcl.2012.08.011     Document Type: Review

References (61)

1. Altu E., Deurdulian C., Elias J., et al. Bladder. Abdominal-pelvic MRI 2010, vol. 2:1297-1341. John Wiley & Sons, Hoboken (NJ).
2. Tekes A., Kamel I., Imam K., et al. Dynamic MRI of bladder cancer: evaluation of staging accuracy. AJR Am J Roentgenol 2005, 184(1):121-127.
3. Maeda H., Kinukawa T., Hattori R., et al. Detection of muscle layer invasion with submillimeter pixel MR images: staging of bladder carcinoma. Magn Reson Imaging 1995, 13(1):9-19.
4. Rosenkrantz A.B., Neil J., Kong X., et al. Prostate cancer: comparison of 3D T2-weighted with conventional 2D T2-weighted imaging for image quality and tumor detection. Am J Roentgenol 2010, 194(2):446-452.
5. Kim B., Semelka R.C., Ascher S.M., et al. Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging. Radiology 1994, 193(1):239-245.
6. Verma S., Rajesh A., Morales H., et al. Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy. Am J Roentgenol 2011, 196(2):374-381.
7. Verma S., Rajesh A., Prasad S.R., et al. Urinary bladder cancer: role of MR imaging. Radiographics 2012, 32(2):371-387.
8. Lawler L.P. MR imaging of the bladder. Radiol Clin North Am 2003, 41(1):161-177.
9. Wong-You-Cheong J.J., Woodward P.J., Manning M.A., et al. Neoplasms of the urinary bladder: radiologic-pathologic correlation1. Radiographics 2006, 26(2):553-580.
10. Jemal A., Siegel R., Xu J., et al. Cancer Statistics, 2010. CA Cancer J Clin 2010, 60(5):277-300.
11. Jewett M.A., Pereira G., Nijmeh P., et al. Increasing incidence, but stable mortality, of bladder cancer in Ontario. Analysis of a population sample. Urology 1991, 37(Suppl 5):4-7.
12. Murta-Nascimento C., Schmitz-Dräger B., Zeegers M., et al. Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J Urol 2007, 25(3):285-295.
13. Sadow C.A., Silverman S.G., O'Leary M.P., et al. Bladder cancer detection with CT urography in an academic medical center1. Radiology 2008, 249(1):195-202.
14. Pashos C.L., Botteman M.F., Laskin B.L., et al. Bladder cancer. Cancer Pract 2002, 10(6):311-322.
15. Wu X.R. Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer 2005, 5(9):713-725.
16. Shariat S.F., Karakiewicz P.I., Ashfaq R., et al. Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy. Cancer 2008, 112(2):315-325.
17. Edge S.B. American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging handbook: from the AJCC cancer staging manual 2010, Springer, New York. 7th edition.
18. Hall T.B., MacVicar A.D. Imaging of bladder cancer. Imaging 2001, 13(1):1-10.
19. Haider E.A., Jhaveri K.S., O'Malley M.E., et al. Magnetic resonance imaging of the urinary bladder: cancer staging and beyond. Can Assoc Radiol J 2008, 59(5):241-258.
20. Zhang J., Gerst S., Lefkowitz R.A., et al. Imaging of bladder cancer. Radiol Clin North Am 2007, 45(1):183-205.
21. Stenzl A., Cowan N.C., De Santis M., et al. The updated EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol 2009, 55(4):815-825.
22. Hayashi N., Tochigi H., Shiraishi T., et al. A new staging criterion for bladder carcinoma using gadolinium-enhanced magnetic resonance imaging with an endorectal surface coil: a comparison with ultrasonography. BJU Int 2000, 85(1):32-36.
23. Scattoni V., Da Pozzo L.F., Colombo R., et al. Dynamic gadolinium-enhanced magnetic resonance imaging in staging of superficial bladder cancer. J Urol 1996, 155(5):1594-1599.
24. Hatano K., Tsuda K., Kawamura N., et al. Nihon Hinyokika Gakkai Zasshi 2010, 101(4):603-608. [in Japanese].
25. Takeuchi M., Sasaki S., Ito M., et al. Urinary bladder cancer: diffusion-weighted MR imaging-accuracy for diagnosing T stage and estimating histologic grade1. Radiology 2009, 251(1):112-121.
26. Siegelman E.S., Schnall M.D. Contrast-enhanced MR imaging of the bladder and prostate. Magn Reson Imaging Clin N Am 1996, 4(1):153-169.
27. Barentsz J.O., Jager G.J., van Vierzen P.B., et al. Staging urinary bladder cancer after transurethral biopsy: value of fast dynamic contrast-enhanced MR imaging. Radiology 1996, 201(1):185-193.
28. Bartsch G.C., Kuefer R., Gschwend J.E., et al. Hydronephrosis as a prognostic marker in bladder cancer in a cystectomy-only series. Eur Urol 2007, 51(3):690-698.
29. Pagano F., Bassi P., Ferrante G.L., et al. Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement. J Urol 1996, 155(1):244-247.
30. Esrig D., Freeman J.A., Elmajian D.A., et al. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion. J Urol 1996, 156(3):1071-1076.
31. Lin G., Ho K.C., Wang J.J., et al. Detection of lymph node metastasis in cervical and uterine cancers by diffusion-weighted magnetic resonance imaging at 3T. J Magn Reson Imaging 2008, 28(1):128-135.
32. Deserno W.M., Harisinghani M.G., Taupitz M., et al. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. Radiology 2004, 233(2):449-456.
33. Thoeny H.C., Triantafyllou M., Birkhaeuser F.D., et al. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients. Eur Urol 2009, 55(4):761-769.
34. Laurent S., Mahmoudi M. Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer. Int J Mol Epidemiol Genet 2011, 2(4):367-390.
35. Kim MY, Kim AY, Ha HK, et al. MRI in rectal cancer: added value of diffusion-weighted imaging (DWI) for discrimination of metastatic lymph nodes. Presented at the 93rd Scientific Assembly and Annual Meeting of the Radiological Society of North America: 2007. Chicago, November 25-30, 2007.
36. Lahaye M.J., Engelen S.M., Kessels A.G., et al. USPIO-enhanced MR imaging for nodal staging in patients with primary rectal cancer: predictive criteria1. Radiology 2008, 246(3):804-811.
37. Koh D.M., Brown G., Collins D.J. Nanoparticles in rectal cancer imaging. Cancer Biomark 2009, 5(2):89-98.
38. Barentsz J.O., Jager G.J., Witjes J.A. MR imaging of the urinary bladder. Magn Reson Imaging Clin N Am 2000, 8(4):853-867.
39. Bradford T.J., Montie J.E., Hafez K.S. The role of imaging in the surveillance of urologic malignancies. Urol Clin North Am 2006, 33(3):377-396.
40. Barentsz J.O., Berger-Hartog O., Witjes J.A., et al. Evaluation of chemotherapy in advanced urinary bladder cancer with fast dynamic contrast-enhanced MR imaging. Radiology 1998, 207(3):791-797.
41. Barentsz J.O., Engelbrecht M., Jager G.J., et al. Fast dynamic gadolinium-enhanced MR imaging of urinary bladder and prostate cancer. J Magn Reson Imaging 1999, 10(3):295-304.
42. Dondalski M., White E.M., Ghahremani G.G., et al. Carcinoma arising in urinary bladder diverticula: imaging findings in six patients. AJR Am J Roentgenol 1993, 161(4):817-820.
43. Durfee S.M., Schwartz L.H., Panicek D.M., et al. MR imaging of carcinoma within urinary bladder diverticulum. Clin Imaging 1997, 21(4):290-292.
44. Montironi R., Lopez-Beltran A. The 2004 WHO classification of bladder tumors: a summary and commentary. Int J Surg Pathol 2005, 13(2):143-153.
45. Shokeir A.A. Squamous cell carcinoma of the bladder: pathology, diagnosis and treatment. BJU Int 2004, 93(2):216-220.
46. Hughes M.J., Fisher C., Sohaib S.A. Imaging features of primary nonurachal adenocarcinoma of the bladder. AJR Am J Roentgenol 2004, 183(5):1397-1401.
47. Rafal R.B., Markisz J.A. Urachal carcinoma: the role of magnetic resonance imaging. Urol Radiol 1991, 12(4):184-187.
48. Bates A.W., Baithun S.I. Secondary neoplasms of the bladder are histological mimics of nontransitional cell primary tumours: clinicopathological and histological features of 282 cases. Histopathology 2000, 36(1):32-40.
49. Martin S.A., Sears D.L., Sebo T.J., et al. Smooth muscle neoplasms of the urinary bladder: a clinicopathologic comparison of leiomyoma and leiomyosarcoma. Am J Surg Pathol 2002, 26(3):292-300.
50. Agrons G.A., Wagner B.J., Lonergan G.J., et al. From the archives of the AFIP. Genitourinary rhabdomyosarcoma in children: radiologic-pathologic correlation. Radiographics 1997, 17(4):919-937.
51. Kim J.C. CT features of bladder small cell carcinoma. Clin Imaging 2004, 28(3):201-205.
52. Martignoni G., Eble J.N. Carcinoid tumors of the urinary bladder. Immunohistochemical study of 2 cases and review of the literature. Arch Pathol Lab Med 2003, 127(1):e22-e24.
53. Binsaleh S., Corcos J., Elhilali M.M., et al. Bladder leiomyoma: report of two cases and literature review. Can J Urol 2004, 11(5):2411-2413.
54. Bates A.W., Norton A.J., Baithun S.I. Malignant lymphoma of the urinary bladder: a clinicopathological study of 11 cases. J Clin Pathol 2000, 53(6):458-461.
55. Yeoman L.J., Mason M.D., Olliff J.F. Non-Hodgkin's lymphoma of the bladder - CT and MRI appearances. Clin Radiol 1991, 44(6):389-392.
56. Chen M., Lipson S.A., Hricak H. MR imaging evaluation of benign mesenchymal tumors of the urinary bladder. AJR Am J Roentgenol 1997, 168(2):399-403.
57. Thrasher J.B., Rajan R.R., Perez L.M., et al. Cystitis glandularis. Transition to adenocarcinoma of the urinary bladder. N C Med J 1994, 55(11):562-564.
58. Kim S.H., Yang D.M., Kim N.R. Polypoid and papillary cystitis mimicking a large transitional carcinoma in a patient without a history of catheterization: computed tomography and magnetic resonance findings. J Comput Assist Tomogr 2004, 28(4):485-487.
59. Umaria N., Olliff J.F. MRI appearances of bladder endometriosis. Br J Radiol 2000, 73(871):733-736.
60. Narla L.D., Newman B., Spottswood S.S., et al. Inflammatory pseudotumor1. Radiographics 2003, 23(3):719-729.
61. Markle B.M., Catena L. Bladder pseudomass following cystography-related bladder trauma. Radiology 1986, 159(1):265.